BAY-4931

CAS No. 423150-91-8

BAY-4931( —— )

Catalog No. M36091 CAS No. 423150-91-8

BAY-4931 is a powerful, covalent, and selective inverse-agonist of PPARγ, exhibiting an IC50 value of 0.17 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 52 Get Quote
5MG 76 Get Quote
10MG 122 Get Quote
25MG 266 Get Quote
50MG 419 Get Quote
100MG 605 Get Quote
500MG 1287 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    BAY-4931
  • Note
    Research use only, not for human use.
  • Brief Description
    BAY-4931 is a powerful, covalent, and selective inverse-agonist of PPARγ, exhibiting an IC50 value of 0.17 nM.
  • Description
    BAY-4931 is a potent, covalent and selective PPARγ inverse-agonist with an IC50 of 0.17 nM.
  • In Vitro
    BAY-4931 (0-10 μM; 7 days) inhibits UM-UC-9 proliferation with an IC50 of 3.4 nM.BAY-4931 only inhibits CYP2C8 in CYP inhibition test.Cell Proliferation Assay Cell Line:UM-UC-9 cells Concentration:0-10 μM Incubation Time:7 days Result:Inhibited proliferation with an IC50 of 3.4 nM.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    PPAR
  • Recptor
    PPAR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    423150-91-8
  • Formula Weight
    421.83
  • Molecular Formula
    C22H16ClN3O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (296.33 mM; Ultrasonic (<70°C)
  • SMILES
    N(C(=O)C1=CC(N(=O)=O)=CC=C1Cl)C=2C=C3C(OC(=N3)C4=CC=C(CC)C=C4)=CC2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Orsi DL, et al. Discovery and Structure-Based Design of Potent Covalent PPARγ Inverse-Agonists BAY-4931 and BAY-0069. J Med Chem. 2022 Nov 10;65(21):14843-14863.?
molnova catalog
related products
  • Chiglitazar

    Chiglitazar (CS-038, CS038) is a potent, dual PPARα/γ dual agonist with EC50 of 1.2, 0.08, 1.7 uM for PPARα, PPARγ and PPARδ, respectively.

  • INT-131

    INT-131, is a novel, non-thiazolidinedione (TZD), selective peroxisome proliferator-activated receptor (PPAR)gamma modulator.

  • Seladelpar

    A potent, selective, orally bioavailable PPARδ agonist for the treatment of dyslipidemia, metabolic syndrome, type 2 diabetes, and non-alcoholic steatohepatitis (NASH).